Insertion, replacement, or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild, moderate or severe chronic heart failure (NYHA II, III or IV)
Medical Services Advisory Committee
Record ID 32015000436
English
Authors' recommendations:
After considering the strength of the available evidence in relation to safety, clinical effectiveness and cost-effectiveness, MSAC supports public funding for cardiac resynchronisation therapy with a cardioverter defibrillator by amending the current MBS items 38371, 38368 and 38654 to also include patients who have mild chronic heart failure symptoms (NYHA Class II) despite optimal medical therapy and who meet the following criteria:
- sinus rhythm
- left ventricular ejection fraction of ≤ 35%
- QRS duration ≥ 150 ms.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1223-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Defibrillators, Implantable
- Cardiac Resynchronization Therapy
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.